FIELD: medicine, pharmacy. SUBSTANCE: agent is gelatin capsule containing mexidol and potato starch, polyvinylpyrrolidone, magnesium stearate and talc as additional substances. EFFECT: increased bioavailability of agent. 2 cl, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
GAMMA-HYDROXYPROPYLAMMONIUM-5-HYDROXYNICOTINATE ELICITING ANTI-ISCHEMIC, ANTI-ARRHYTHMIC AND HYPOLIPIDEMIC ACTIVITY | 2003 |
|
RU2245329C1 |
2-ETHYL-6-METHYL-3-HYDROXYLIRIDINIUMHYDROXYBUTANEDIOAT EXPRESSING ANTI-ISHEMIC, CEREBROPROTECTIVE, NEUROTROPIC AND LIPID-REGULATING ACTIVITY, PHARMACEUTICAL COMPOSITIONS AND MEDICAL PRODUCT | 2008 |
|
RU2377237C1 |
PHARMACEUTICAL COMBINATION POSSESSING ANTIAGGREGANT AND LIPID-REGULATING ACTIVITIES, PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2461379C2 |
AGENT WITH HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTION | 2008 |
|
RU2372897C1 |
HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENT | 2007 |
|
RU2372923C2 |
COMBINATION POSSESSING ANTIAGGREGANT, LIPID-REGULATING AND GASTROPROTECTIVE ACTIVITIES, PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2453314C1 |
AGENT WITH HYPOLIPIDEMIC ACTIVITY | 2004 |
|
RU2268714C1 |
MEDICATION FOR PREVENTION AND TREATMENT OF ATHEROSLEROSIS | 2011 |
|
RU2468789C1 |
AGENT POSSESSING HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTIVITY | 2015 |
|
RU2598347C1 |
HYPOLIPIDEMIC AGENT | 2008 |
|
RU2392933C2 |
Authors
Dates
2000-01-27—Published
1998-03-24—Filed